Schizophrenia Spectrum Disorder
6
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
Personalized Metacognitive Training for Psychosis: A Randomized Controlled Trial
Childhood Maltreatment, Traumatic Experiences and Stress-associated Parameters in Schizophrenia Spectrum Disorders
tDCS and Executive Function Training for Schizophrenia
Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder
RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)